Vaccine for tuberculosis effective against Covid-19 in Type 1 diabetes patients
2 min read
Having Type 1 diabetes is a risk factor for developing illness from circulating viruses and bacteria, which can lead to hospitalization, disability, and death. The Covid-19 pandemic has been especially challenging for individuals with diabetes as the current data demonstrates the risk of contracting and suffering severe illness from this disease is significantly increased for individuals with pre-existing diabetes. As widely known, vaccines are essential in helping prevent serious disease development and subsequent complications.
Thanks to researchers at Massachusetts General Hospital’s Department of Immunobiology, a new study demonstrates that people with Type 1 diabetes who received three doses of a vaccine created in the early 1920s to prevent tuberculosis, called Bacillus-Calmette Guerin (BCG), were protected from developing severe infection from Covid-19 and several other diseases.
Check out the full media article from Science Direct, or read the direct research paper by clicking the link below:
